A Phase IIIb Study to Investigate the Effect of Baxdrostat in Chinese Participants With Uncontrolled Hypertension.
Clinical trial NCT07686120 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686120
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2028-02-09
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.